SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
RxNorm 2664844

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2664844 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 mg/ML Injection
Primary clinical definition
AUI:12852230
View
PSN
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
AUI:12852240
View
SY
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
AUI:12852239
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 mg/ML Injection
(Atom ID: 12852230)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2664844
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12852230
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2664844
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSN

Prescribable Name (PSN):
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
(Atom ID: 12852240)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2664844
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12852240
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2664844
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
(Atom ID: 12852239)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine 2023-2024, mRNA-BNT162b2 OMICRON (XBB.1.5) Injection, 12y+
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2664844
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12852239
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2664844
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.